The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT01034800
First received: December 16, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted

December 16, 2009
December 16, 2009
September 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215

The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....

The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
HIV Infections
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided
  • Data analysis protocol
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01034800
999906300, 06-DA-N300
Not Provided
Not Provided
National Institute on Drug Abuse (NIDA)
Not Provided
Not Provided
National Institutes of Health Clinical Center (CC)
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP